Michael Hill
DPhil
Laboratory Scientific Director
Associate Professor Mike Hill joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2009 and is the Laboratory Scientific Director of the Wolfson Laboratories. He has a background in population-based studies and functional studies associated with respiratory and cardiovascular disease.
He manages a team of 40 research and technical staff and is responsible for senior strategic oversight of all aspects of laboratory research within Oxford Population Health. Mike works closely with the department's principal investigators, providing central laboratory support for their clinical trials and observational studies ensuring the scientific integrity of the laboratory work.
Research interests include investigating new biochemical markers and validating analytical methods suitable for large-scale research. Wolfson Laboratories are a UKAS accredited testing laboratory (ISO 17025:2017 No. 2799) with extensive computer automation and a particular expertise in developing reliable high-throughput methods of analysis in clinical chemistry and protein biomarkers.
Mike gained his DPhil at the University of Oxford in 1992 and continued his post-doctoral studies at the Nuffield Department of Clinical Medicine, Oxford and The Wellcome Trust Centre for Human Genetics, Oxford. In 1998, he joined the Division of Medicine at University College London where he led a research group.
Recent publications
-
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.
Journal article
Yang L. et al, (2024), Int J Epidemiol, 53
-
PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations.
Journal article
Holmes MV. et al, (2024), Eur J Prev Cardiol, 31, 1015 - 1025
-
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.
Journal article
Yao P. et al, (2024), Diabetes Care, 47, 1012 - 1019
-
Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
Journal article
Kartsonaki C. et al, (2024), Int J Cancer, 154, 1423 - 1432
-
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Journal article
Ziyatdinov A. et al, (2024), Nature, 626